MG1102

· Green Cross Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MG1102, covering 2015-11-26 to 2015-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of MG1102 in Patients With Solid Tumors [Phase 1]